|
|
||||||||
Vol. 273, Issue 5, C1657-C1665, November 1997
Department of Physiology and Biophysics, School of Medicine, Wright State University, Dayton, Ohio 45435
| |
ABSTRACT |
|---|
|
|
|---|
ML-1 cell proliferation is dependent on the presence of serum growth factors. Removing serum from the culture medium results in growth arrest and promotes differentiation. In this study, we found that a 4-aminopyridine-sensitive K+ channel was highly expressed in proliferating ML-1 cells and significantly diminished in G1-arrested ML-1 cells induced by serum deprivation but was restored within 30 min in these cells with addition of 10% fetal bovine serum (FBS) or 5 ng/ml epidermal growth factor (EGF). Intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels, but not guanosine 3',5'-cyclic monophosphate, were significantly increased in serum-deprived cells stimulated by FBS or EGF, and the effects of FBS and EGF on the channel activation were mimicked by exogenous cAMP. In inside-out patches, K+ channel activity was significantly increased by the cAMP-dependent protein kinase catalytic subunit, whereas the effect of EGF on K+ channel activation was blocked by Rp-8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphothioate. Together, our results demonstrate that serum growth factors stimulate K+ channel activity in proliferation of ML-1 cells through protein kinase-induced phosphorylation and suggest an important molecular mechanism for serum growth factor-stimulated mitogenesis in ML-1 cells.
patch clamp; adenosine 3',5'-cyclic monophosphate; protein kinase A; epidermal growth factor; DNA synthesis
| |
INTRODUCTION |
|---|
|
|
|---|
HUMAN MYELOBLASTIC leukemia (ML-1) cells proliferate in tissue culture as immature myeloblasts, and this proliferation is stimulated by various growth factors present in the culture serum. ML-1 cells can be programmed to differentiate into granulocytes or macrophages when specifically stimulated (4), and these differentiated cells play significant roles in the immune defense system and require membrane-mediated transduction of cell-cell and cell-environment signals. Our previous studies demonstrated that a voltage-gated K+ current in ML-1 cells was altered during the entire process of differentiation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) and revealed that K+ channel activity varied depending on the stage of ML-1 cell proliferation and differentiation (18). Channel activity was dramatically diminished in the early stages of TPA-induced ML-1 cell differentiation and was completely suppressed in differentiated cells. However, it is still unclear how voltage-gated K+ channel activity is regulated and what is the precise role of this channel in ML-1 cell proliferation and differentiation.
Ion channels located at the cell membrane sense chemical and physical changes in the cell growth environment and mediate functional adaptation of the cell to environmental changes. In excitable tissues, such as nerves and muscle and some hormone-releasing cells, voltage-dependent K+ channels play important roles in regulation of cell electrical activities in response to various stimulations. Voltage-dependent K+ channels also play crucial roles in cell development, volume regulation, membrane potential stabilization, and proliferation (5, 6, 8, 13, 20). A variety of studies have suggested that the voltage-gated K+ channel plays a functional role in the onset of cellular events associated with both T and B lymphocyte activation (1, 17, 21). It has been found that enhanced K+ channel gene expression or increased K+ channel activity is associated with mitogenesis in several cell types (21). Application of different K+ channel blockers to cultured cells significantly inhibits various types of cell proliferation (1, 7, 10). Recently, the important role of the voltage-gated K+ channel in mitogenesis has been suggested to be a key determinant for cell progression through G1 phase before the G1 checkpoint in ML-1 and other cells (10, 16, 32). In K+ channel activity-suppressed ML-1 cells, retinoblastoma protein (pRB) is dephosphorylated and effectively inhibits the cell from progressing through the G1/S transition (32).
To investigate the precise role the voltage-gated K+ channel plays in growth factor-mediated ML-1 cell proliferation, we have designed a series of experiments to study mechanisms that underlie the correlation of channel activity to ML-1 cell growth control and the effect of growth factors on K+ channel activity during ML-1 cell proliferation. We found that the growth-related K+ channel activity was markedly diminished in serum-deprived cells, and channel activity could be restored to its full activity within 30 min after physiological concentrations of serum or epidermal growth factor (EGF) were applied to the patch chamber. EGF-stimulated K+ channel activity was mediated through elevation of intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels and activation of cAMP-dependent protein kinase (PKA)-induced phosphorylation. Our results suggest that the K+ channel in ML-1 cells is regulated by growth factor-mediated intracellular signaling pathways and plays an important role in controlling cell proliferation, specifically in the G1/S transition of the cell cycle.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture. ML-1 cells were originally isolated from an acute myeloblastic leukemia patient and were received as a generous gift from Dr. R. W. Craig, Dartmouth Medical School (Hanover, NH). Cells were maintained in suspension culture as described previously (18). Briefly, culture medium RPMI 1640 containing 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer was supplemented with 7.5% heat-inactivated fetal bovine serum (FBS; GIBCO, Grand Island, NY). For the high-K+ culture medium, NaCl in the RPMI 1640 medium was isotonically replaced by 135 mM KCl. Cells were grown in a humidified incubator with 5% CO2 at 37°C and passed at a seeding density of 3 × 105 cells/ml. Cells were washed twice with phosphate buffer solution (PBS) before they were transferred for patch-clamp experiments.
Cell growth assays. Proliferation of ML-1 cells was determined by counting cell numbers and measuring [3H]thymidine incorporation into the host DNA. ML-1 cells from suspension cultures were plated in triplicate into 35-mm culture dishes at a density of 3 × 105 cells/ml. The effect of K+ channel blockers on cell growth was tested by dilution of concentrated stock solution directly into the plating medium. After incubation for 4 or 24 h, all cultures were pulsed with 1 µCi/ml [3H]thymidine for 2 h. Cells were then harvested and washed twice with PBS. Nucleic acids were precipitated with 10% trichloroacetic acid, and radioactivity of samples was quantified by liquid scintillation counting. Growth arrest induced by serum deprivation was achieved by culturing cells in RPMI 1640 medium containing 0.3% FBS at 37°C for 24 h.
Intracellular cAMP and guanosine 3',5'-cyclic monophosphate assays. ML-1 cells were synchronized in the G1 phase of the cell cycle by serum deprivation for 24 h. Cells were then aliquoted into 35-mm culture dishes at a final concentration of 1 × 106 cells/ml and were stimulated with either 10% FBS or 5 ng/ml EGF. At the times indicated, cells were collected and washed twice with ice-cold PBS and then resuspended in 1 ml of 65% (vol/vol) ice-cold ethanol. After they had settled for 60 min at 22°C, supernatants were drawn into new test tubes and remaining precipitates were washed with ice-cold 65% ethanol. Washing solutions were added into the appropriate tubes. Cell extracts were centrifuged at 2,000 g for 15 min at 4°C, and supernatants were transferred into fresh tubes. The extracts were then dried overnight by a vacuum lyophilizer. Intracellular cAMP and guanosine 3',5'-cyclic monophosphate (cGMP) levels were assayed with the use of the enzyme immunoassay system (EIA, nonacetylation protocol) provided by Amersham Life Sciences (Buckinghamshire, UK).
Patch-clamp studies.
Both cell-attached and inside-out patch-clamp techniques were used in
the present study. Detailed methods for the patch pipette preparation,
data acquisition, and single-channel analysis were described previously
(31). Briefly, pipettes were manufactured with a two-stage puller
(PP-83, Narishige) with a resistance of 3-4 M
when filled with
150 mM KCl solution. The solutions used in these experiments were
1) KCl bath solution containing (in mM) 140 KCl, 2 MgCl2, 0.5 CaCl2, 1 ethylene
glycol-bis(
-aminoethyl ether)-N,N,N',N'-tetraacetic
acid, and 10 HEPES (pH 7.4) and 2) pipette solution containing (in mM) 140 KCl, 2 MgCl2, 1 CaCl2, and 10 HEPES (pH 7.4).
Single-channel currents were recorded with an Axonpatch 200A amplifier
(Axon Instruments, Foster City, CA) and filtered with a four-pole
low-pass filter at 1 kHz and digitalized at 22 kHz by a pulse-code
modulator (A. R. Vetter, Rebersburg, PA). The pCLAMP program (Axon
Instruments) was used to analyze the single-channel data. The channel
activity was determined as NPo, where
N represents number of channel
openings in the patch and
Po represents the
channel open probability. All experiments were performed at room
temperature (21-23°C). Data are presented as original values
or as means ± SE, when indicated. Significant differences were
determined by using the paired t-test
at the confidence interval indicated.
Reagents.
The catalytic subunit of PKA, MgATP, dithiothreitol (DTT),
8-(4-chlorophenylthio)-cAMP (CPT-cAMP), and 4-aminopyridine (4-AP) were
purchased from Sigma Chemical (St. Louis, MO).
Rp-8-(4-chlorophentlthio)adenosine 3',5'-monophosphothioate
(Rp-CPT-cAMPS) and EGF were obtained from Biolog Life Science (La Jolla, CA) and Calbiochem (La Jolla, CA),
respectively. The catalytic subunit of PKA was diluted in KCl bath
solution, and 1 mg/ml DTT was added to the mixture. The mixture was
then allowed to stand for 10 min at room temperature (22°C) before
use or before storage at
80°C.
K+ channel blockers were prepared
as stock solutions with concentrations of 500 mM to 1 M in sterile
water.
| |
RESULTS |
|---|
|
|
|---|
A voltage-gated K+ channel in proliferating ML-1 cells. A voltage-gated and 4-AP-sensitive K+ channel at the whole cell level in ML-1 cells has been shown previously (18). To investigate the role of this channel in growth factor-mediated ML-1 cell proliferation, single K+ channel currents were measured (Fig. 1A). The microscopic current-voltage (I-V) relationship was linear with a single-channel conductance of 31 ± 0.7 pS (measured from the slope of I-V curves; n = 6) in symmetric 140/140 mM KCl solution (Fig. 1B). When extracellular KCl was isotonically replaced with NaCl, the inward current was abolished (Fig. 1B), suggesting selectivity of this channel for K+. The K+-selective channel was also confirmed pharmacologically by demonstrating sensitivity of the channel to extracellular 4-AP. Channel activity was inhibited 63 and 97% by extracellular application of 50 or 100 µM 4-AP, respectively (Fig. 1C). These results indicate that the single-channel current is carried by K+ through a 4-AP-sensitive K+ channel.
|
Serum growth factors activate the K+
channel.
Proliferation of ML-1 cells is dependent on various serum growth
factors in the culture medium. If the
K+ channel plays a role in growth
factor-mediated ML-1 cell proliferation, then channel activity should
be regulated by serum growth factors. To test this hypothesis, the
precise role of this channel in growth factor-mediated ML-1 cell
proliferation was determined by patch-clamp experiments. Possible
regulatory effects of serum growth factors on
K+ channel function were examined
with the cell-attached patch clamp. Channel activity was observed in
ML-1 cells cultured with serum-rich medium (with 7.5% FBS), and the
channel was frequently open with an average activity
(NPo) of 21 ± 5.5% (at
60 mV, n = 9)
in cell-attached patches (Table 1). In
contrast, channel activity was significantly diminished to an
NPo of 0.4 ± 0.2% (at
60 mV, n = 16, P < 0.001) in ML-1 cells that were
cultured in serum-free medium (with 0.3% FBS) for at least 12 h (Fig.
2A). The
specific effect of growth factors on channel activity was studied by
addition of 10% FBS onto serum-starved cells. When 10% FBS was
applied in the patch chamber, channel activity was restored in
cell-attached patches in a few minutes and reached full activity within
30 min (Fig. 2B). Channel activity
was significantly increased, from 0.4 ± 0.2% to 40 ± 15%
within 30 min and to 57 ± 5% after 30 min
(n = 6, P < 0.001) (Fig.
2C). In some patches lasting for 150 min or longer, high channel activity was observed continuously. Thus these findings suggest that K+
channel function in proliferating ML-1 cells is regulated by serum
growth factors.
|
|
Intracellular signaling pathway stimulated by serum growth factors. To investigate the possible intracellular signaling pathway involved in regulating K+ channel activity, intracellular cAMP and cGMP concentrations were measured before and after stimulation with 10% FBS in growth-arrested ML-1 cells. The intracellular cAMP level was significantly increased within 5 min (P < 0.001) after FBS treatment and continued to rise for 55 min (Fig. 3). Because it has been shown that EGF stimulates cAMP production in cardiac myocytes (18, 19) and hepatoma cells (20), we examined the effect of EGF on the cAMP levels in ML-1 cells. When 5 ng/ml EGF was applied to growth-arrested ML-1 cells in culture, the intracellular cAMP concentration was significantly increased within 5 min and reached a plateau level at 30 min (Fig. 3). On the other hand, application of FBS or EGF did not significantly increase intracellular cGMP levels.
|
60 mV was significantly increased,
from 0.4 ± 0.2% to 47 ± 15% within 30 min and to 48 ± 16% after 30 min (n = 4, P < 0.001). The time course showed
that the increase of EGF-induced
K+ channel activity was parallel
to the increase of intracellular cAMP level (Fig.
4B). It was notable that there was a
lag phase (a few minutes) in the increase of the channel activity.
Increasing the concentration of EGF to 25 ng/ml stimulated the
K+ channel activity in
serum-deprived ML-1 cells, but there was no further increase after 30 min (data not shown). Effects of FBS and EGF on
K+ channel activity were not a
voltage-dependent process in hematopoietic ML-1 cells when the membrane
potential was varied from
60 to +60 mV (Fig.
4C). To further confirm the effect
of cAMP on K+ channel regulation,
100 µM CPT-cAMP, a membrane-permeable cAMP analog, was added directly
to serum-deprived ML-1 cells in the patch chamber. Channel activity was
stimulated by CPT-cAMP within a few minutes (Fig.
4D) and significantly increased to
65 ± 12% (n = 8) within 30 min
(Table 1). Together, these results suggest that the intracellular
signaling pathway for the growth factor-mediated K+ channel activity involves
production of the second messenger cAMP and that EGF may be one of the
growth factors that stimulates this pathway.
|
Verification of PKA involvement.
To further characterize the intracellular signaling pathway and the
potential involvement of PKA-induced phosphorylation in growth
factor-mediated K+ channel
activation, inside-out patches from ML-1 cells cultured in normal
medium were exposed to a phosphorylation mixture solution containing
MgATP and the catalytic subunit of PKA. Excised patches were held at
60 mV for 2 min to measure control channel activity, and then 1 mM MgATP was added to the patch bath solution.
K+ channel activity was not
significantly changed during a waiting period of 7-10 min. Then,
50 nM PKA catalytic subunit was added in the bath, resulting in a
significant increase in
NPo from 15 ± 3.2% to 38 ± 5.1% (n = 4, P < 0.05) in 5-10 min (Fig.
5A and Table 1). In inside-out patches that were not exposed to the phosphorylation mixture solution,
K+ activity faded away within
10-30 min after patch excision. Results from these experiments
suggest that phosphorylation of the channel protein induced by PKA is
required to maintain the normal activity of the
K+ channel in these cells. This
conclusion was further supported by experiments that demonstrated that
Rp-CPT-cAMPS, an antagonist of PKA,
blocked channel activity induced by EGF in serum-deprived ML-1 cells
(Fig. 5B). Cell-attached patches
were held at
60 mV, and 5 ng/ml EGF was then added to stimulate
channel activity. Rp-CPT-cAMPS (100 µM) was added to the patched cell after a dramatic increase of
channel activity was observed (5 min). The
K+ channel activity induced by EGF
was significantly diminished, from 47 ± 15% to 10 ± 3%
(n = 4, P < 0.01), within 30-50 min
after application of 100 µM
Rp-CPT-cAMPS (Fig.
5C).
|
Effect of suppressed K+ channel activity on ML-1 cell proliferation. The effect of inhibition of K+ channel on ML-1 cell proliferation was evaluated by adding K+ channel blockers in the culture medium individually or by replacing Na+ with K+ in the medium and by monitoring cell numbers and DNA synthesis measured by [3H]thymidine incorporation. ML-1 cells were growth arrested in the G1 phase by culturing cells in serum-deprived medium for 24 h. Growth-arrested cells were then released into normal culture medium with 7.5% FBS (controls), in 135 mM K+ medium with 7.5% FBS (high K+ medium), or in normal culture medium containing 7.5% FBS plus 2 mM 4-AP, 2.5 mM BaCl2, 10 mM tetraethylammonium, or 30 µM quinine. After applications of different K+ channel blockers at the indicated concentrations or in the high-K+ concentration culture condition for 24 h, there were no significant changes in cell viability measured with the trypan blue exclusion method. Viability measurements of ML-1 cells in the absence and presence of different K+ channel blockers and in high-K+ concentration culture condition are summarized in Table 2. The fractional inhibition of DNA synthesis was measured at 4 and 24 h after release of growth-arrested cells. Rates of [3H]thymidine incorporation after exposure to different channel blockers or the high-K+ concentration culture condition were significantly inhibited as early as 4 h and reached a much higher level at 24 h (Fig. 6). These results suggest that blockade of the K+ channel by K+ channel blockers and growing cells in the high-K+ concentration medium inhibited DNA synthesis, preventing ML-1 cells from progressing through the G1 phase to S phase of the cell cycle.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
K+ channel activity has been found
to influence cell proliferation and differentiation in various systems
(2, 13, 18). In the present study, we demonstrate that
K+ channel activity is closely
correlated to serum growth factor-stimulated ML-1 cell proliferation.
In proliferating ML-1 cells, the
K+ channel activity was observed
in abundance (Table 1), but this activity was greatly suppressed in
serum-deprived ML-1 cells that were synchronized in the
G1 phase of the cell cycle (32).
The diminished K+ channel activity
in serum-deprived cells was then restored within 30 min by direct
exposure of ML-1 cells to physiological concentrations of FBS and EGF
(Figs. 2 and 4). Activation of K+
channels by serum growth factors has been found in other cell types.
For example, in PC-12 cells, nerve growth factor regulates the
abundance and distribution of delayed rectifier
K+ channels (24) and exposure of
resting microglial cells to interferon-
or granulocyte/macrophage
colony-stimulating factor results in an inhibition of outward
K+ current (11). These results
suggest that a shift of the resting membrane potential to more
hyperpolarized levels may be a prerequisite for intracellular
mechanisms involved in macrophage and microglial cell activity.
Generally, effects of growth factors and cytokines on
K+ channel activity can be divided
into long-term and short-term effects. The short-term effect is
characterized by altering channel gating, most likely through second
messenger-mediated modulation of channel protein. However, the
long-term effect corresponds to the maximal
K+ conductance affected by total
channel numbers resulting from altered
K+ channel gene expression and
insertion of channel proteins to the membrane. In human cultured
oligodendrocytes, inward rectifier K+ channels were modulated by
tumor necrosis factor-
(TNF-
), a cytokine associated with
activated macrophages (19, 25). Treatment of oligodendrocytes with
TNF-
for 24-48 h significantly decreases expression of the
K+ channel gene and diminishes the
mean open time of the K+ channel
relative to control value. These data suggest that TNF-
possesses
both short- and long-term effects on the inward rectifier K+ channel in human
oligodendrocytes. In the present study, activation of
K+ channels in ML-1 cells by 10%
FBS or 5 ng/ml EGF can be considered a short-term effect of serum
growth factors.
Growth factor/cytokine receptor-mediated second messenger systems, such as the cAMP cascade, have been suggested to modulate K+ channel function, and a number of different experimental approaches have been used to study the role of the cAMP cascade in modulating K+ channel activity. Intracellular levels of cAMP may be increased artificially by injection of cAMP through microelectrodes, extracellular application of membrane-permeable cAMP analogs, such as dibutyryl cAMP or 8-bromo-cAMP, use of phosphodiesterase inhibitors, or use of the diterpene compound forskolin, a direct activator of adenylate cyclase (20). Using EIA, we found that the effect of serum growth factors or EGF on ML-1 cells was mediated through regulation of intracellular cAMP levels but not intracellular cGMP levels (Fig. 3). The effect of increased intracellular cAMP levels on K+ channel activity was verified by direct application of CPT-cAMP (Fig. 4D). Increased intracellular cAMP can further activate PKA, leading to phosphorylation of serine/threonine residues on a variety of substrate proteins, including ion channels.
The present study demonstrates that serum growth factor-stimulated K+ channel activity is mediated via cAMP-dependent phosphorylation. Using the inside-out patch clamp, we confirmed that serum growth factor-regulated K+ channels in ML-1 cells can be activated by direct phosphorylation by the PKA catalytic subunit in vitro (Fig. 5A). Furthermore, we found that the effect of EGF on K+ channel activity can be blocked by the PKA inhibitor Rp-CPT-cAMPS (Fig. 5B). These results raise the interesting possibility that PKA mediates the effects of growth factors on ion channels and other proteins. A large body of evidence has shown that protein phosphorylation by PKA is an important cellular mechanism modulating K+ channel function. The phosphorylation state of the channel subunits or associated proteins can influence the amplitude or the time course of current initiated by a change of membrane potential or ligand binding (7). For example, the delayed rectifier K+ channel in Aplysia bag cell neurons, the K+ channel in hippocampal neurons, and Ca2+-activated K+ channels in neuroendocrine cells are also inhibited by cAMP analogs via activation of PKA (26, 29). However, it is important to point out that PKA-mediated phosphorylation can induce the opposite effect in different voltage-gated K+ channels. For instance, the anomalous rectifier K+ channel functions in Aplysia neurons and cardiac cells are upregulated by activation of PKA (2, 12, 27). PKA-mediated phosphorylation affects the opening probability and the Ca2+ or voltage sensitivity of rat brain Ca2+-activated K+ channels reconstituted into artificial lipid bilayers (23). Correlation of PKA-mediated modulation of intrinsic channel characteristics with the direct phosphorylation of a K+ channel has been demonstrated for three distinct voltage-gated K+ channels belonging to the Shaker subfamily. Therefore, by integrating electrophysiological and molecular biology techniques in a Xenopus oocyte expression system, the inactivation gating of the Shaker K+ channels and the opening time that a single Kv1.2 channel spends in different conductance states were shown to be regulated by PKA-induced phosphorylation at the COOH-terminal region of the channels (9, 14). Direct phosphorylation of channel proteins by PKA has been demonstrated biochemically for the Shaker K+ channels purified from rat (Kv1.1) or bovine brain (Kv1.2) (15). The opening probabilities of these channel on reconstituted lipid bilayers and the Kv1.3 channel residing in T lymphocyte membrane can be increased by cAMP-dependent phosphorylation (3, 22).
We have shown that K+ channel activity was extremely low in growth-arrested ML-1 cells and that channel activity can be restored by addition of 10% FBS (Fig. 2). To study how the effect of growth factors on the channel activity might influence cell proliferation, [3H]thymidine incorporation was used to measure ML-1 cells entering the S phase and proliferation (Fig. 6). Suppression of K+ channel activity by different K+ channel blockers effectively prevented growth-arrested ML-1 cells from entering the S phase of the cell cycle. It has been shown that pRB controls cell proliferation at the G1 check point of the cell cycle, whereas pRB dephosphorylation causes G1 arrest in many cell types (28). We have shown that increases in the dephosphorylated form of pRB is an important event in the loss of proliferation in K+ channel-suppressed ML-1 cells (32). Our results have demonstrated that the effect of K+ channel inhibition on ML-1 cell proliferation is a phase-specific event.
In summary, the investigation of a functional role for a growth-associated K+ channel in human myeloblastic ML-1 cell proliferation has provided new evidence that K+ channel activity involves growth factor-mediated G1/S transition of the cell cycle. Activity of this channel is closely associated with this stage of cell growth and is controlled by serum growth factors through the intracellular cAMP and cAMP-dependent kinase cascades. PKA-mediated phosphorylation of this K+ channel resulted in increased activity that paralleled serum growth factor-stimulated cell proliferation. Our findings also provide an additional molecular mechanism supporting a role for K+ channel activity in the G1/S transition of the cell cycle, and this mechanism constitutes a novel means of controlling ML-1 cell proliferation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. R. W. Craig for giving us ML-1 cells as a generous gift.
| |
FOOTNOTES |
|---|
This study was supported by National Institute of General Medical Sciences Grant GM-46834 (to L. Lu) and was partially supported by National Heart, Lung, and Blood Institute Grant HL-54844 (to R. E. White) and by a grant from the American Foundation for Aging Research (to R. E. White).
Address for reprint requests: L. Lu, Dept. of Physiology and Biophysics, School of Medicine, Wright State Univ., Dayton, OH 45435.
Received 6 January 1997; accepted in final form 17 June 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Amigorena, S.,
D. Choquet,
J. L. Teillaud,
H. Korn,
and
W. H. Fridman.
Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels.
J. Immunol.
144:
2038-2045,
1990[Abstract].
2.
Benson, J. A.,
and
I. B. Levitan.
Serotonin increases an anomalously rectifying K+ current in the Aplysia neuron R15.
Proc. Natl. Acad. Sci. USA
80:
3522-3525,
1983
3.
Cai, Y. C.,
and
J. Douglass.
In vivo and in vitro phosphorylation of the T lymphocyte type n (Kv1.3) potassium channel.
J. Biol. Chem.
268:
23720-23727,
1993
4.
Craig, R. W.,
O. S. Frankfurt,
H. Sakagami,
K. Takeda,
and
A. Bloch.
Macromolecular and cell cycle effects of different classes of agents including the maturation of human myeloblastic leukemia (ML-1) cells.
Cancer Res.
44:
2421-2429,
1984
5.
Day, M. L.,
S. J. Pickering,
M. H. Johnson,
and
D. I. Cook.
Cell-cycle control of a large-conductance K+ channel in mouse early embryos.
Nature
365:
560-562,
1993[Medline].
6.
Decoursey, T. E.,
K. G. Chandy,
S. Gupta,
and
M. D. Cahalan.
Mitogen induction of ion channels in murine T lymphocytes.
J. Gen. Physiol.
89:
405-420,
1987
7.
Deterre, P.,
D. Paupardin-Tritsch,
J. Bockaert,
and
H. M. Gerschenfeld.
Role of cyclic AMP in a serotonin-evoked slow inward current in snail neurones.
Nature
290:
783-785,
1981[Medline].
8.
Deutsch, C.,
and
L. Q. Chen.
Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation.
Proc. Natl. Acad. Sci. USA
90:
10036-10040,
1993
9.
Drain, P.,
A. E. Dubin,
and
R. W. Aldrich.
Regulation of Shaker K+ channel inactivation gating by the cAMP-dependent protein kinase.
Neuron
12:
1097-1099,
1994[Medline].
10.
Dubois, J. M.,
and
B. Rouzaire-Dubois.
Role of potassium channels in mitogenesis.
Prog. Biophys. Mol. Biol.
59:
1-21,
1993[Medline].
11.
Fischer, H. G.,
C. Eder,
U. Hadding,
and
U. Heinemann.
Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states.
Neuroscience
64:
183-191,
1995[Medline].
12.
Frace, A. M.,
and
H. C. Hartzell.
Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes.
J. Physiol. (Lond.)
472:
305-326,
1993
13.
Freedman, B. D.,
B. K. Fleischmann,
J. A. Punt,
G. Gaulton,
Y. Hashimoto,
and
M. I. Kotlikoff.
Identification of Kv1.1 expression by murine CD4-CD8- thymocytes. A role for voltage-dependent K+ channels in murine thymocyte development.
J. Biol. Chem.
270:
22406-22411,
1995
14.
Huang, X. Y.,
A. D. Morielli,
and
E. G. Peralta.
Molecular basis of cardiac potassium channel stimulation by protein kinase A.
Proc. Natl. Acad. Sci. USA
91:
624-628,
1994
15.
Ivanina, T.,
T. Perets,
W. B. Thornhill,
G. Levin,
N. Dascal,
and
I. Lotan.
Phosphorylation by protein kinase A of RCK1 K+ channels expressed in Xenopus oocytes.
Biochemistry
33:
8786-8792,
1994[Medline].
16.
Lewis, R. S.,
and
M. D. Cahalan.
Ion channels and signal transduction in lymphocytes.
Annu. Rev. Physiol.
52:
415-430,
1990[Medline].
17.
Lin, C. S.,
R. C. Boltz,
J. T. Blake,
M. Nguyen,
A. Talento,
P. A. Fischer,
M. S. Springer,
N. H. Sigal,
R. S. Slaughter,
M. L. Garcia,
G. J. Kaczorowski,
and
G. C. Koo.
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.
J. Exp. Med.
177:
637-645,
1993
18.
Lu, L.,
T. Yang,
D. Markakis,
W. B. Guggino,
and
R. W. Craig.
Alterations in a voltage-gated K+ current during the differentiation of ML-1 human myeloblastic leukemia cells.
J. Membr. Biol.
132:
267-274,
1993[Medline].
19.
McLarnon, J. G.,
M. Michikawa,
and
S. U. Kim.
Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes.
Glia
9:
120-126,
1993[Medline].
20.
Pappone, P. A.,
and
S. I. Ortiz-Miranda.
Blockers of voltage-gated K channels inhibit proliferation of cultured brown fat cells.
Am. J. Physiol.
264 (Cell Physiol. 33):
C1014-C1019,
1993
21.
Price, M.,
S. C. Lee,
and
C. Deutsch.
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.
Proc. Natl. Acad. Sci. USA
86:
10171-10175,
1989
22.
Rehm, H.,
S. Pelzer,
C. Cochet,
E. Chambaz,
B. L. Tempel,
W. Trautwein,
D. Pelzer,
and
M. Lazdunski.
Dendrotoxin-binding brain membrane protein displays a K+ channel activity that is stimulated by both cAMP-dependent and endogenous phosphorylations.
Biochemistry
28:
6455-6460,
1989[Medline].
23.
Reinhart, P. H.,
S. Chung,
B. L. Martin,
D. L. Brautigan,
and
I. B. Levitan.
Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A.
J. Neurosci.
11:
1627-1635,
1991[Abstract].
24.
Seamon, K. B.,
and
J. W. Daly.
Forskolin: a unique diterpene activator of cyclic AMP-generating systems.
J. Cyclic Nucleotide Res.
7:
201-224,
1981[Medline].
25.
Soliven, B.,
S. Szuchet,
and
D. J. Nelson.
Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.
J. Membr. Biol.
124:
127-137,
1991[Medline].
26.
Strong, J. A.,
and
L. K. Kaczmarek.
Multiple components of delayed potassium current in peptidergic neurons of Aplysia: modulation by an activator of adenylate cyclase.
J. Neurosci.
6:
814-822,
1986[Abstract].
27.
Walsh, K. B.,
and
R. S. Kass.
Distinct voltage-dependent regulation of a heart-delayed IK by protein kinases A and C.
Am. J. Physiol.
261 (Cell Physiol. 30):
C1081-C1090,
1991
28.
Weinberg, R. A.
The retinoblastoma protein and cell cycle control.
Cell
81:
323-330,
1995[Medline].
29.
White, R. E.,
A. Schonbrunn,
and
D. L. Armstrong.
Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation.
Nature
351:
570-573,
1991[Medline].
30.
Woodfork, K. A.,
W. F. Wonderlin,
V. A. Peterson,
and
J. S. Strobl.
Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture.
J. Cell. Physiol.
162:
163-171,
1995[Medline].
31.
Xu, B.,
and
L. Lu.
Protein kinase A-regulated Cl
channel in ML-1 human hematopoietic myeloblasts.
J. Membr. Biol.
142:
65-75,
1994[Medline].
32.
Xu, B.,
B. A. Wilson,
and
L. Lu.
Induction of human myeloblastic ML-1 cell G1 arrest by suppression of K+ channel activity.
Am. J. Physiol.
271 (Cell Physiol. 40):
C2037-C2044,
1996
This article has been cited by other articles:
![]() |
O. Bardou, N. T. N. Trinh, and E. Brochiero Molecular diversity and function of K+ channels in airway and alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L145 - L155. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. N. Trinh, A. Prive, E. Maille, J. Noel, and E. Brochiero EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L866 - L880. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. N. Trinh, A. Prive, L. Kheir, J.-C. Bourret, T. Hijazi, M. G. Amraei, J. Noel, and E. Brochiero Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L870 - L882. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Guo, J. Lu, T. Li, Z. Lu, G. Xu, M. Xu, L. Lu, and W. Dai Insulin-activated, K+-channel-sensitive Akt pathway is primary mediator of ML-1 cell proliferation Am J Physiol Cell Physiol, August 1, 2005; 289(2): C257 - C263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manikkam, Y. Li, B. M. Mitchell, D. E. Mason, and L. C. Freeman Potassium Channel Antagonists Influence Porcine Granulosa Cell Proliferation, Differentiation, and Apoptosis Biol Reprod, July 1, 2002; 67(1): 88 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, P. S. Reinach, and W. W.-Y. Kao Corneal Epithelial Wound Healing Experimental Biology and Medicine, July 1, 2001; 226(7): 653 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, L. Wang, W. Dai, and L. Lu A Requirement for K+-Channel Activity in Growth Factor-Mediated Extracellular Signal-Regulated Kinase Activation in Human Myeloblastic Leukemia ML-1 Cells Blood, July 1, 1999; 94(1): 139 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, D. Xu, W. Dai, and L. Lu An Ultraviolet-activated K+ Channel Mediates Apoptosis Of Myeloblastic Leukemia Cells J. Biol. Chem., February 5, 1999; 274(6): 3678 - 3685. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |